RAD51C pathogenic variants

About

Biomarker type: Germline variant

Gene context: RAD51C

Chromosome: 17

Requires pathogenic: True

Mappings
View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations Biomarkers Cancer types Therapies
FDA (1) RAD51C pathogenic variants Prostate Adenocarcinoma Olaparib
FDA (1) HC (1) RAD51C pathogenic variants Prostate Adenocarcinoma Enzalutamide, Talazoparib